Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

High-Throughput GLP-Capable Target Cell Visualization Assay for Measuring Cell-Mediated Cytotoxicity (2018) Welter A, Sundararaman S, Li R, Zhang T, Karulin AY, Lehmann A, Naeem V, et al. Journal article Does vagus nerve stimulation influence pregnancy outcomes? (2018) Sabers A, Buchgreitz L, Neuhuber W Journal article APTES-Terminated ultrasmall and iron-doped silicon nanoparticles as X-Ray dose enhancer for radiation therapy (2018) Klein S, Wegmann M, Distel L, Neuhuber W, Kryschi C Journal article Digital pathology imaging and computer-aided diagnostics as a novel tool for standardization of evaluation of aganglionic megacolon (Hirschsprung disease) histopathology (2018) Schilling F, Geppert CI, Strehl J, Hartmann A, Kürten S, Brehmer A, Jabari S Journal article Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis (2018) Simon M, Ipek R, Homola GA, Rovituso DM, Schampel A, Kleinschnitz C, Kürten S Journal article B Cells and B Cell Blasts Withstand Cryopreservation While Retaining Their Functionality for Producing Antibody (2018) Fecher P, Caspell R, Naeem V, Karulin AY, Kürten S, Lehmann P Journal article Direct Detection of T- and B-Memory Lymphocytes by ImmunoSpot® Assays Reveals HCMV Exposure that Serum Antibodies Fail to Identify (2018) Terlutter F, Caspell R, Nowacki TM, Lehmann A, Li R, Zhang T, Przybyla A, et al. Journal article ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro (2018) Schmid R, Wolf K, Robering JW, Strauss S, Strissel P, Strick R, Rübner M, et al. Journal article Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018) Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al. Conference contribution The sacral autonomic outflow: against premature oversimplification (2018) Jaenig W, Mclachlan EM, Neuhuber W Journal article